title: [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders].
abstract: In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of short and long-term endocrine dysfunction following allogeneic stem cell transplantation. The key aim of this workshop was to give an overview on dyslipidemia and thyroid disorders post-transplant.
authors.affiliation: Service d'hématologie adulte, institut de cancérologie de la Loire, 108 bis, avenue Albert-Raimond, Saint-Priest-en-Jarez, France.
authors.forename: J
authors.initials: J
authors.lastname: Cornillon
authors.forename: M-C
authors.initials: MC
authors.lastname: Vantyghem
authors.forename: M A
authors.initials: MA
authors.lastname: Couturier
authors.forename: E
authors.initials: E
authors.lastname: de Berranger
authors.forename: S
authors.initials: S
authors.lastname: François
authors.forename: E
authors.initials: E
authors.lastname: Hermet
authors.forename: N
authors.initials: N
authors.lastname: Maillard
authors.forename: A
authors.initials: A
authors.lastname: Marcais
authors.forename: R
authors.initials: R
authors.lastname: Tabrizi
authors.forename: C
authors.initials: C
authors.lastname: Decanter
authors.forename: R
authors.initials: R
authors.lastname: Duléry
authors.forename: F
authors.initials: F
authors.lastname: Bauters
authors.forename: I
authors.initials: I
authors.lastname: Yakoub-Agha
mesh_terms: D002755:Choice Behavior; D032921:Consensus; D004032:Diet; D050171:Dyslipidemias / Q000209:etiology / Q000628:therapy*; D004700:Endocrine System Diseases / Q000209:etiology* / Q000628:therapy*; D058607:Fibric Acids / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000592:standards; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008991:Monitoring, Physiologic / Q000379:methods / Q000592:standards; D013959:Thyroid Diseases / Q000209:etiology / Q000628:therapy*; D014184:Transplantation, Homologous
chemical_list: D058607:Fibric Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Allogeneic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; Dyslipidemia; Dyslipidémie; Guideline; Metabolic dysfunction; Thyroid disorders; Thyropathie; Troubles métaboliques